Science Explorer Interactive view Map
Nonprofit · Tokyo · Japan

Japan Society of Chemotherapy

chemotherapy.or.jpROR OpenAlex
World rank, all time
#25,343
of 42,892
Rank in Japan
#1,006
of 2,112
Research works
172
▼ 53% vs 2013–17
Citations
6.4k
37.3 per fractional work
Top-10% rate
17.1%
record average 16.5%
Open access
32%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.48× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.65× its world share, 4 worksBiochemistry, Geneti…Immunology and Microbiology: 7.84× its world share, 1 worksImmunology and Micro…Neuroscience: 0.55× its world share, 0 worksNeuroscienceChemistry: 0.38× its world share, 0 worksChemistryEngineering: 0.09× its world share, 0 worksEngineeringEnvironmental Science: 0.09× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.20× its world share, 0 worksMaterials ScienceDentistry: 0.33× its world share, 0 worksDentistryMedicine: 2.31× its world share, 4 worksMedicineVeterinary: 3.26× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.8×. Every wedge is a field page.

Who are the top researchers at Japan Society of Chemotherapy?

Ranked on the composite score, Hiroko Takeda lead among researchers whose main affiliation is Japan Society of Chemotherapy.

  1. 1 Hiroko Takeda Japan · #878,315 worldwide 5 citations · 21 works
All ranked researchers at Japan Society of Chemotherapy

Which keywords describe research at Japan Society of Chemotherapy?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Cancer, Immunotherapy, Survival Analysis, Metastatic Breast Cancer, Chemotherapy-Induced Peripheral Neuropathy, Taxanes and Clinical Practice Guidelines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy25▲ 20×19 topics
  2. Epidemiology15▲ 2.1×43 topics
  3. Cancer14▲ 6.0×30 topics
  4. Immunotherapy11▲ 9.5×13 topics
  5. Quality of Life10▲ 4.5×5 topics
  6. Survival Analysis10▲ 21×5 topics
  7. Metastatic Breast Cancer10▲ 84×2 topics
  8. Chemotherapy-Induced Peripheral Neuropathy9▲ 108×1 topic
  9. Taxanes9▲ 108×1 topic
  10. Clinical Practice Guidelines9▲ 9.5×6 topics
  11. Antibiotic Resistance9▲ 13×9 topics
  12. Gastric Cancer8▲ 38×3 topics
  13. Molecular Characterization8▲ 24×6 topics
  14. Tumor Microenvironment8▲ 12×6 topics
  15. Gene Therapy7▲ 16×3 topics
  16. Prognostic Factors7▲ 9.3×10 topics
  17. Cancer Therapy7▲ 6.2×14 topics
  18. Endoscopic Resection7▲ 41×2 topics
  19. Adjuvant Therapy6▲ 31×2 topics
  20. Lymph Node Dissection6▲ 60×1 topic
  21. Neoadjuvant Chemotherapy6▲ 40×1 topic
  22. Clinical Trials6▲ 5.5×7 topics
  23. Molecular Subtypes6▲ 37×2 topics
  24. PET Imaging5▲ 14×4 topics
  25. Targeted Therapy5▲ 14×5 topics
  26. Tumor Regression5▲ 34×2 topics
  27. Therapeutic Targets5▲ 12×5 topics
  28. Treatment Guidelines5▲ 14×3 topics
  29. Cetuximab5▲ 35×2 topics
  30. Molecular Profiling5▲ 23×3 topics
  31. Precision Medicine5▲ 9.0×3 topics
  32. Signal Transduction5▲ 11×5 topics
  33. Breast Cancer5▲ 9.8×6 topics
  34. Metastasis5▲ 8.1×7 topics
  35. Tumor Targeting5▲ 21×3 topics
  36. Fluorouracil5▲ 80×1 topic
  37. KRAS Mutations5▲ 80×1 topic
  38. Immunity4▲ 7.7×6 topics
  39. Antimicrobial Resistance4▲ 10×5 topics
  40. RNA Regulation4▲ 23×2 topics

Which research topics does Japan Society of Chemotherapy publish most on?

By volume in 2022–2025: Cancer, Hypoxia, and Metabolism, RNA modifications and cancer, Intraperitoneal and Appendiceal Malignancies and ATP Synthase and ATPases Research.

Cancer, Hypoxia, and Met…0Cancer, Hypoxia, and Metabolism: 0 fractional worksRNA modifications and ca…0RNA modifications and cancer: 0 fractional worksIntraperitoneal and Appe…0Intraperitoneal and Appendiceal Malignancies: 0 fractional worksATP Synthase and ATPases…0ATP Synthase and ATPases Research: 0 fractional worksGallbladder and Bile Duct Disorders: 0 fractional worksEsophageal and GI Pathology: 0 fractional worksPI3K/AKT/mTOR signaling …0PI3K/AKT/mTOR signaling in cancer: 0 fractional worksLung Cancer Treatments a…0Lung Cancer Treatments and Mutations: 0 fractional worksCancer-related Molecular…0Cancer-related Molecular Pathways: 0 fractional worksAntibiotic Use and Resis…0Antibiotic Use and Resistance: 0 fractional works
Cancer ResearchMolecular BiologySurgeryPulmonary and Respiratory Medicine2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer, Hypoxia, and Metabolism Cancer Research 0 works
  2. 2 RNA modifications and cancer Molecular Biology 0 works
  3. 3 Intraperitoneal and Appendiceal Malignancies Surgery 0 works
  4. 4 ATP Synthase and ATPases Research Molecular Biology 0 works
  5. 5 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
  6. 6 Esophageal and GI Pathology Surgery 0 works
  7. 7 PI3K/AKT/mTOR signaling in cancer Molecular Biology 0 works
  8. 8 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
  9. 9 Cancer-related Molecular Pathways Oncology 0 works
  10. 10 Antibiotic Use and Resistance Applied Microbiology and Biotechnology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available31.6%not open68.4%

World: 28% of research is openly available.

with international co-authors29.7%domestic only70.3%

World: 19% is written across borders.

How has Japan Society of Chemotherapy's research output changed?

Output in 2018–2022 was 53% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Tokyo

All research institutions in Tokyo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.